flanders.bio is a dynamic, member driven organisation with currently more than 350 members from Belgium and abroad. We help our members to create value by organising Networking and Training Activities, supporting Internationalisation, providing Services and building Expertise. flanders.bio and its members want to be the proud advocates of a reputable global-impact ecosystem in life sciences.
News from flanders.bio and its members
MDxHealth (R): SelectMDx Included in Dutch DRG Reimbursement System
MDxHealth SA ("MDxHealth, or the "Company"), (Euronext: MDXH.BR), a world leader in molecular diagnostics for urological cancers, today announced the inclusion of SelectMDx for Prostate Cancer, its non-invasive 'liquid biopsy' test that helps to identify patients at increased risk of having aggressive prostate cancer, in the Dutch Diagnosis Related Groups (DRG) reimbursement system.
Galapagos creates new warrant plan
Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its board of directors created 1,585,000 warrants under new warrant plans for the benefit of employees, future employees, directors and a consultant of the company and its subsidiaries.
VIB presents its 2017 annual results and confirms its reputation as global player
VIB is home to world-class researchers who are working across disciplines to tackle some of society’s major challenges. In eight thematic research centers, VIB creates opportunities for knowledge pooling which leads to inspiring collaborations between scientists within the centers and beyond. VIB’s proactive approach to technology transfer engages its researchers to convert their research results into concrete, marketable “products”.
UgenTec Announces partnership with Serosep Ltd.
We're excited to announce today our partnership with Serosep Ltd., a leading global manufacturer of molecular solutions for clinical laboratories. In the partnership, we will add the Serosep EntericBio assay range to our platform FastFinder.